Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in Colombia

Table 2

Clinical and demographic characteristics of patients with positive serological markers for HBV and HCV.

Code	Diagnosis	Origin	Age	Gender	Alcohol*	Type of simple		Serological marker
						Serum	Liver tissue	HBsAg	Anti-HCV
UdeA-001	Ci	Colombia	68	F	4	NA	Yes	Neg	Pos
UdeA-002	Ci	Colombia	59	M	4	NA	Yes	Neg	Pos
UdeA-003	Ci	Colombia	68	M	4	NA	Yes	Neg	Pos
UdeA-004	Ci	Colombia	47	M	4	Yes	NA	Pos	Neg
UdeA-006	HCC + Ci	Colombia	48	M	4	NA	Yes	Neg	Pos
UdeA-009	Ci	Colombia	69	M	1	Yes	NA	Pos	Neg
UdeA-015	HCC + Ci	Colombia	68	F	9	NA	Yes	Neg	Pos
UdeA-024	Ci	El Salvador	60	M	9	NA	Yes	Pos	Neg
UdeA-054	Ci	Venezuela	47	M	3	Yes	Yes	Pos	Neg
UdeA-056	HCC + Ci	Colombia	56	F	4	Yes	NA	Pos	Neg
UdeA-058	HCC + Ci	Colombia	53	M	9	Yes	NA	Pos	Neg
UdeA-061	Ci	Colombia	47	F	4	Yes	NA	Pos	Neg
UdeA-065	Ci	Colombia	58	F	1	NA	Yes	Neg	Pos
UdeA-069	HCC	Colombia	64	F	4	NA	Yes	Neg	Pos
UdeA-070	Ci	Colombia	34	M	4	NA	Yes	Neg	Pos
UdeA-072	Ci	Israel	49	M	3	Yes	Yes	Pos	Neg
UdeA-077	Ci	Colombia	57	M	1	Yes	NA	Pos	Neg
UdeA-083	HCC + Ci	Colombia	67	F	4	Yes	Yes	Pos	Neg
UdeA-087	Ci	Colombia	48	M	2	Yes	NA	Pos	Neg
UdeA-089	HCC + Ci	Colombia	47	F	4	Yes	Yes	Pos	Neg
UdeA-099	Ci	Colombia	56	M	4	Yes	NA	Pos	Neg
UdeA-101	Ci	Colombia	74	F	4	Yes	NA	Pos	Neg
UdeA-124	HCC + Ci	Colombia	57	M	2	Yes	NA	Pos	Neg

ci: Cirrhosis, HCC: hepatocellular carcinoma, M: male, F: female, *Alcohol intake: for male/(female) 1: >80 g/day (40g/day); 2: 50–80 g/day (20–40 g/day); 3: <50 g/day (20 g/day) 4: no intake; 9: no data; Yes: available; NA: nonavailable; Yes: HBV/HCV-positive sample by molecular analysis; Pos: positive serological result;Neg: negative serological result.